What is GSK2798745 used for?

GSK2798745 is being researched for treating heart failure, pulmonary edema, cough, and macular edema.

Is GSK2798745 an approved medication?

No, GSK2798745 is currently a research compound in clinical trial phases and is not yet approved for public use.

What is the purpose of studying GSK2798745?

Researchers are studying this molecule to see if it can help manage conditions like heart failure and fluid in the lungs.

Can GSK2798745 treat eye problems?

Studies are looking into whether GSK2798745 might be used to treat macular edema.

Safety data for general use is not yet available as the drug is still in the clinical testing stages.

What kind of drug is GSK2798745?

GSK2798745 is categorized as a small molecule drug.

Gsk-2798745 | CAS 1419609-94-1 | URCMKDJBULWNAI

Loading compound...

Small molecule research compound

GSK2798745 is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat conditions like heart failure, pulmonary edema, and macular edema.

How it worksThe exact way GSK2798745 works in the body is not yet fully detailed for consumers, but it is a small molecule designed to target specific biological processes.

Used for

Heart failurePulmonary edema (fluid in the lungs)CoughMacular edema

Conditions

Heart FailurePulmonary EdemaCoughMacular Edema

Class

Small moleculeSmall molecule research compoundCardiovascular systemRespiratory systemVisual system

How to take

This drug is currently in the research and development phase (Max Phase 2) and is not yet approved for general consumer use by regulatory agencies like the FDA.

Talk to your doctor

Questions to ask

·What stage of clinical trials is GSK2798745 currently in?
·How might GSK2798745 affect heart failure management?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)